comparemela.com

Latest Breaking News On - Buesa - Page 1 : comparemela.com

ORYZON Reports Financial Results and Corporate Updates for Quarter Ended September 30, 2023

27.10.2023 - Positive aggregate safety data from vafidemstat s fully enrolled PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and .

ORYZON Reports Financial Results and Corporate Updates for Half-Year Ending June 30, 2023

24.07.2023 - Positive aggregate safety data from vafidemstat s PORTICO Phase IIb trial in Borderline Personality Disorder (BPD), consistent with safety data from seven completed clinical trials, supporting the drug is safe and well-toleratedContinues to enroll .

vimarsana © 2020. All Rights Reserved.